SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Director/PDMR Shareholding

7 Dec 2006 10:44

Rentokil Initial PLC07 December 2006 NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIALRESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.(2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and 24.(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes should in block capital letters. 1. Name of the issuer RENTOKIL INITIAL PLC.................. 2. State whether the notification relates to (i) a transaction notified inaccordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (asextended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) (iii) BOTH (i) and (ii).................................... 3. Name of person discharging managerial responsibilities/director ANDREW MACFARLANE..................... 4. State whether notification relates to a person connected with a persondischarging managerial responsibilities/director named in 3 and identify theconnected person ...N/A................................. 5. Indicate whether the notification is in respect of a holding of the personreferred to in 3 or 4 above or in respect of a non-beneficial interest BENEFICIAL HOLDING OF PERSON NAMED IN (3).............................. 6. Description of shares (including class), debentures or derivatives orfinancial instruments relating to shares ORDINARY 1PENCE........................ 7. Name of registered shareholders(s) and, if more than one, the number ofshares held by each of them ANDREW MACFARLANE......... .................................... 8 State the nature of the transaction ACQUISITION AND SALE OF PART TO SATISFY TAX LIABILITY .................................... 9. Number of shares, debentures or financial instruments relating to sharesacquired 101,667.................................... 10. Percentage of issued class acquired (treasury shares of that class shouldnot be taken into account when calculating percentage) ...0.0556%................................. 11. Number of shares, debentures or financial instruments relating to sharesdisposed 41,638.................. 12. Percentage of issued class disposed (treasury shares of that class shouldnot be taken into account when calculating percentage) 0.0223.................................... 13. Price per share or value of transaction 147.25 (PURCHASE AND SALE).................................... 14. Date and place of transaction 6 DECEMBER 2006......LONDON.............................. 15. Total holding following notification and total percentage holding followingnotification (any treasury shares should not be taken into account whencalculating percentage) 59,984.................................... 16. Date issuer informed of transaction 6 DECEMBER 2006.................................... If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17 Date of grant ............N/A........................ 18. Period during which or date on which it can be exercised ...............N/A..................... 19. Total amount paid (if any) for grant of the option ..................N/A.................. 20. Description of shares or debentures involved (class and number) .....................N/A............... .................................... 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at the time of exercise .....................N/A............... 22. Total number of shares or debentures over which options held followingnotification .....................N/A............... 23. Any additional information ...SALE TO SATISFY TAX LIABILITY................................. 24. Name of contact and telephone number for queries PAUL GRIFFITHS 020 7866 3021.................................... Name and signature of duly authorised officer of issuer responsible for makingnotification .................................... Date of notification ...7DECEMBER 2006................................. END This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th Jul 20253:00 pmRNSHolding(s) in Company
10th Jul 202511:00 amRNSHolding(s) in Company
1st Jul 202510:25 amRNSTotal Voting Rights
10th Jun 202510:05 amRNSAdditional Listing
3rd Jun 20254:00 pmRNSDirector/PDMR Shareholding
28th May 20257:00 amRNSSale of France Workwear
19th May 20252:30 pmRNSDirector/PDMR Shareholding
7th May 20254:15 pmRNSResult of AGM
7th May 20257:01 amRNSDirectorate Change: Appointment of NEDs
7th May 20257:00 amRNSDirectorate Change: Chief Executive to retire
28th Apr 20252:30 pmRNSIssue of Debt
17th Apr 20252:20 pmRNSHolding(s) in Company
17th Apr 20257:00 amRNSQ1 Trading Update
9th Apr 202510:25 amRNSHolding(s) in Company
1st Apr 20252:15 pmRNSNotice of Q1 Trading Update and Management Call
1st Apr 202510:25 amRNSBlock listing Interim Review
27th Mar 202510:25 amRNSDirector/PDMR Shareholding
26th Mar 202510:30 amRNSAnnual Financial Report
14th Mar 202510:00 amRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNSFinal Results
28th Jan 20257:00 amRNSTrading Update (unaudited)
14th Jan 202511:15 amRNSHolding(s) in Company
13th Jan 202511:15 amRNSHolding(s) in Company
13th Dec 20249:30 amRNSDirector/PDMR Shareholding
25th Nov 20247:00 amRNSDirectorate Change
12th Nov 202410:30 amRNSHolding(s) in Company
8th Nov 202410:30 amRNSHolding(s) in Company
17th Oct 20247:00 amRNSQ3 Trading Update
1st Oct 20242:00 pmRNSBlock listing Interim Review
25th Sep 20247:00 amRNSAppointment of Non-Executive Director
19th Sep 202410:30 amRNSDirector/PDMR Shareholding
11th Sep 20247:00 amRNSTrading Update
10th Sep 202410:30 amRNSHolding(s) in Company
5th Sep 202411:08 amRNSHolding(s) in Company
25th Jul 20247:00 amRNS2024 Interim Results
10th Jul 20244:35 pmRNSHolding(s) in Company
26th Jun 20245:12 pmRNSDirector/PDMR Shareholding
26th Jun 202411:08 amRNSHolding(s) in Company
17th May 20243:30 pmRNSDirector/PDMR Shareholding
8th May 20242:00 pmRNSResult of AGM
29th Apr 20243:00 pmRNSHolding(s) in Company
23rd Apr 20249:30 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSQ1 Trading Update
2nd Apr 20241:28 pmRNSBlock listing Interim Review
2nd Apr 202412:17 pmRNSTotal Voting Rights
27th Mar 202410:23 amRNSAnnual Financial Report
19th Mar 20242:05 pmRNSAdditional Listing
14th Mar 202410:19 amRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFinal Results
1st Dec 20237:00 amRNSNorth American Management Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.